Loading...
Loading...
TXG| Name | Value |
|---|---|
| Revenues | 184.0M |
| Cost of Revenue | 77.9M |
| Gross Profit | 106.1M |
| Operating Expense | 141.7M |
| Operating I/L | -35.6M |
| Other Income/Expense | -11.0M |
| Interest Income | 4.6M |
| Pretax | -46.6M |
| Income Tax Expense | 2.4M |
| Net Income/Loss | -49.0M |
10x Genomics, Inc. is a life science technology company that develops and sells instruments, consumables, and software for analyzing biological systems globally. The company's products include chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables for single cell solutions, such as gene expression, immune profiling, epigenetics, and multiome ATAC + gene expression. Additionally, it offers visium spatial gene expression solutions for spatial gene expression patterns and protein co-detection. 10x Genomics serves academic, government, biopharmaceutical, biotechnology, and other institutions with its innovative solutions.
